H.P. Acthar Gel Prospective Registry: A Prospective Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis (MS) Relap
Aims: This study aims to characterize the patient population and describe MS exacerbation recovery, treatment patterns and safety outcomes in patients who receive Acthar Gel to treat acute MS exacerbations.
Principal Investigator: Afif Hentati, MD
NorthShore Project Number: EH15-398
Contact: Please call 847.570.1439 with questions regarding the study
Open to Enrollment: Yes